Literature DB >> 3964764

Abnormal clearance of immune complexes from the circulation of patients with primary sclerosing cholangitis.

G Y Minuk, M Angus, C M Brickman, T J Lawley, M M Frank, J H Hoofnagle, E A Jones.   

Abstract

The ability of fixed macrophages of the reticuloendothelial system to clear circulating immune complexes was studied in 6 patients with primary sclerosing cholangitis, 5 patients with various other forms of chronic liver disease, and 12 normal control subjects. Autologous red cells were radiolabeled with 51Cr and sensitized with anti-Rh(D) immunoglobulin G in vitro. After intravenous infusion of the labeled antibody-coated red cells, the radioactivity content of timed blood specimens was measured. The time required by the reticuloendothelial system to clear one-half the labeled cells from the circulation (t1/2) was then determined. The t1/2 clearance times were significantly prolonged in all 6 patients with primary sclerosing cholangitis, whereas the clearance times in 4 of the 5 liver disease control patients were either normal or shortened. Serum immunoglobulin G and immunoglobulin M immune complex levels did not correlate with t1/2 clearance times. These results suggest that in primary sclerosing cholangitis there is a defect in the ability of fixed macrophages of the reticuloendothelial system to mediate clearance of circulating particles that have been opsonized with immunoglobulin G. This finding further supports recent data that incriminates the immune system in the pathogenesis of primary sclerosing cholangitis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3964764     DOI: 10.1016/s0016-5085(85)80149-9

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  18 in total

Review 1.  Immunological abnormalities and hepatotropic viral infections.

Authors:  I G McFarlane
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

2.  Review.

Authors:  Christopher B O'Brien
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-08

3.  Suppressor T-cell deficiency in primary sclerosing cholangitis. Case and family study.

Authors:  A E Kilby; E L Krawitt; R J Albertini; B F Chastenay; A John
Journal:  Dig Dis Sci       Date:  1991-09       Impact factor: 3.199

Review 4.  Relationship of extraintestinal involvements in inflammatory bowel disease: new insights into autoimmune pathogenesis.

Authors:  K M Das
Journal:  Dig Dis Sci       Date:  1999-01       Impact factor: 3.199

5.  Tissue distribution of autoantigen specific for primary sclerosing cholangitis.

Authors:  S K Lo; R W Chapman; K A Fleming
Journal:  J Clin Pathol       Date:  1993-03       Impact factor: 3.411

Review 6.  The immunology of primary sclerosing cholangitis.

Authors:  R W Chapman
Journal:  Springer Semin Immunopathol       Date:  1990

7.  Bile duct antibodies crossreacting with blood group antigens in primary sclerosing cholangitis.

Authors:  G P Jeffrey; N R Swanson; L J Yarred; W D Reed
Journal:  Gut       Date:  1990-06       Impact factor: 23.059

8.  Inappropriate expression of blood group antigens on biliary and colonic epithelia in primary sclerosing cholangitis.

Authors:  S Bloom; A Heryet; K Fleming; R W Chapman
Journal:  Gut       Date:  1993-07       Impact factor: 23.059

Review 9.  Fc receptor-mediated signal transduction.

Authors:  C T Lin; Z Shen; P Boros; J C Unkeless
Journal:  J Clin Immunol       Date:  1994-01       Impact factor: 8.317

Review 10.  Primary sclerosing cholangitis.

Authors:  Y Ueno; N F LaRusso
Journal:  J Gastroenterol       Date:  1994-08       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.